Literature DB >> 32666232

Use of diffusion-weighted imaging in the noninvasive diagnostic of obstructed biliary ducts.

Eliane Donato Leite Paro1, Andrea Puchnick2, Jacob Szejnfeld2, Suzan Menasce Goldman2.   

Abstract

OBJECTIVE: This study sought to evaluate the role of diffusion-weighted imaging (DWI) in differentiation between obstructed and unobstructed bile ducts in patients undergoing magnetic resonance imaging (MRI).
METHODS: Eighty-four patients, 40 males and 44 females (mean age: 56.4 ± 15.1 years), undergoing MRI with DWI (0-50-500-700) were evaluated and divided into two groups: 58 with abnormal laboratory tests (obstructed group) and 26 with normal laboratory values (unobstructed group). Laboratory tests were total bilirubin, alkaline phosphatase, and gamma-glutamyltransferase. Median ADC values were calculated and correlated with laboratory tests and degree of bile-duct dilatation (absent, moderate, or severe). The persistence of signal on DWI (b500 and b700) in the biliary tract was evaluated. Bilirubin values were tested for correlation with bile-duct ADC values and persistence of b700 signal. For statistical analysis, Student t test, chi-square test and Wilcoxon-Mann-Whitney test were used. ADC maps were plotted for three levels of the biliary tree, and a receiver operating characteristic (ROC) curve was calculated.
RESULTS: In the obstructed group, 15 patients had severe dilatation, 24 had moderate dilatation, and 19 had no appreciable dilatation; 38 patients had persistent signal on b700 images. In the unobstructed group, 23 patients had no dilatation and 3 had moderate dilatation; 4 patients had persistent signal on b700 images. Correlation was found between degree of bile-duct dilatation, bilirubin levels, persistence of b700 signal, and ADC map values. The calculated ADC map cutoff value (353 10-6 mm2/s) was able to differentiate the obstructed and unobstructed groups with 92.3% sensitivity, 81% specificity, and 91.9% accuracy.
CONCLUSIONS: DWI is able to distinguish patients with obstructed versus unobstructed bile ducts, regardless of the degree of dilatation, correlating with clinical and laboratory findings.

Entities:  

Keywords:  Bile ducts; Cholangiopancreatography; Cholestasis; Diffusion magnetic resonance imaging; Magnetic imaging resonance

Mesh:

Year:  2020        PMID: 32666232     DOI: 10.1007/s00261-020-02636-x

Source DB:  PubMed          Journal:  Abdom Radiol (NY)


  37 in total

Review 1.  Pancreatic and biliary endoscopy.

Authors:  W R Brugge; J Van Dam
Journal:  N Engl J Med       Date:  1999-12-09       Impact factor: 91.245

2.  A new grading system to evaluate the risk of endoscopic retrograde cholangiopancreatography.

Authors:  Ina Zuber-Jerger; Esther Endlicher; Frank Kullmann; Cornelia M Gelbmann
Journal:  J Gastroenterol       Date:  2009-02-13       Impact factor: 7.527

3.  AN INNOVATIVE EX-VIVO MODEL FOR RAPID CHANGE OF THE PAPILLA FOR TEACHING ADVANCED ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY PROCEDURES.

Authors:  Everson L A Artifon; Thaisa S Nakadomari; Leandro Y Kashiwagui; Emilio A Belmonte; Cláudio R Solak; Spencer Cheng; Carlos K Furuya; Jose P Otoch
Journal:  Arq Bras Cir Dig       Date:  2016 Nov-Dec

Review 4.  Complications of endoscopic retrograde cholangiopancreatography: spectrum of abnormalities demonstrated with CT.

Authors:  H K Pannu; E K Fishman
Journal:  Radiographics       Date:  2001 Nov-Dec       Impact factor: 5.333

Review 5.  BOTOX: Broadening the Horizon of Dentistry.

Authors:  Pranav Nayyar; Pravin Kumar; Pallavi Vashisht Nayyar; Anshdeep Singh
Journal:  J Clin Diagn Res       Date:  2014-12-05

6.  Prospective comparison of transcutaneous 3-dimensional US cholangiography, magnetic resonance cholangiography, and direct cholangiography in the evaluation of malignant biliary obstruction.

Authors:  Michael Hünerbein; Christian Stroszczynski; Christoph Ulmer; Tim Handke; Roland Felix; Peter M Schlag
Journal:  Gastrointest Endosc       Date:  2003-12       Impact factor: 9.427

Review 7.  Diagnostic and therapeutic approach to cholestatic liver disease.

Authors:  T Pérez Fernández; P López Serrano; E Tomás; Ma L Gutiérrez; J L Lledó; G Cacho; C Santander; C M Fernández Rodríguez
Journal:  Rev Esp Enferm Dig       Date:  2004-01       Impact factor: 2.086

Review 8.  Adverse effects of biliary obstruction: implications for treatment of patients with obstructive jaundice.

Authors:  R V Rege
Journal:  AJR Am J Roentgenol       Date:  1995-02       Impact factor: 3.959

9.  Qualification for endoscopic retrograde cholangiopancreatography in the diagnosis and treatment of extrahepatic cholestasis caused by choledocholithiasis.

Authors:  Krzysztof Kujawski; Magdalena Stasiak; Jacek Rysz
Journal:  Arch Med Sci       Date:  2015-12-11       Impact factor: 3.318

10.  ERCP PERFORMANCE IN A TERTIARY BRAZILIAN CENTER: FOCUS ON NEW RISK FACTORS, COMPLICATIONS AND QUALITY INDICATORS.

Authors:  Alana Costa Borges; Paulo César de Almeida; Stella Maria Torres Furlani; Marcelo de Sousa Cury; Douglas K Pleskow
Journal:  Arq Bras Cir Dig       Date:  2018-06-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.